Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma
THZ531衍生物的构效关系研究发现了BSJ-01-175,它是一种对尤文氏肉瘤有效的双重CDK12/13共价抑制剂。
期刊:European Journal of Medicinal Chemistry
影响因子:5.9
doi:10.1016/j.ejmech.2021.113481
Jiang, Baishan; Jiang, Jie; Kaltheuner, Ines H; Iniguez, Amanda Balboni; Anand, Kanchan; Ferguson, Fleur M; Ficarro, Scott B; Seong, Bo Kyung Alex; Greifenberg, Ann Katrin; Dust, Sofia; Kwiatkowski, Nicholas P; Marto, Jarrod A; Stegmaier, Kimberly; Zhang, Tinghu; Geyer, Matthias; Gray, Nathanael S